Monday, October 26, 2026 · Daily editionET --:--:--

Maker's videoCMR Surgical · 22 July 2026

What if surgical robots could help to anticipate, plan and adapt in order to support surgeons?

Watch on YouTube

Against the record

Versius, from CMR Surgical, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 12 Oct 2026: Stryker agreed to invest about $400 million in CMR Surgical and become the only sales agent for Versius in the US. Stryker also got an option to buy the whole company later. The deal still needs regulatory approval.

This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.

From the video's description

CMR Surgical is proud to showcase the next advance in surgical robotics at Society of Robotic Surgery | SRS 2026 from today, 22 July 2026. CMR will demonstrate the potential for Versius Plus™ to leverage surgical data to help predict how a procedure may unfold using NVIDIA Isaac for Healthcare’s Medical Physics Simulation framework. Visit our stand at Booth 101 at SRS 2026 to find out more. This is an exciting milestone for the future of intelligent surgery, creating new opportunities to help deliver safer, more consistent care in the operating room. It has the potential to support surgeon decision-making and contribute to improved patient outcomes. We’re proud to be partnering with NVIDIA to help shape what comes next for surgical robotics, bringing together clinical experience, advanced data and cutting-edge AI to transform surgery. For good. cmrsurgical.com Connect with us: Twit…

Written by CMR Surgical on YouTube.